ASH Practice Changing Updates in AML: Maintenance Oral Aza, Lower Intensity Combos With Aza & HMA + Ven in Newly Diagnosed AML, Ven + Gilteritinib & Menin Inhibitor in R/R Disease

122 views
March 8, 2021
0 Comments
Login to view comments. Click here to Login
6th Annual Updates from ASH 2020